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doi:10.1Objectives:An array of neuroprotective strategies has evolved to limit spinal cord injury during descending tho-
racic aneurysm and thoracoabdominal aortic aneurysm repair. This study prospectively assessed the neuropro-
tective impact of intrathecal papaverine added to other techniques in aortic aneurysm repairs.
Methods: From January 2002 to January 2010, 398 consecutive patients underwent descending thoracic
aneurysm and thoracoabdominal aortic aneurysm repairs at Cleveland Clinic, 68 under hypothermic circulatory
arrest. We focused on the remaining 330, in whom a combination of neuroprotective adjuncts was used intra-
operatively to mitigate spinal cord ischemia. These included distal aortic perfusion with moderate hypothermia,
cerebrospinal fluid drainage, and intrathecal papaverine. Two patient groups were discriminated according to
whether intrathecal papaverine was (n ¼ 250) or was not (n ¼ 80) administered. Postoperative outcomes
were analyzed from a prospectively maintained clinical database.
Results: Preoperative patient characteristics and comorbidities were similar between groups. Extent of aortic
disease was also similar: descending thoracic aneurysm (34% with papaverine vs 28%) and Crawford types
I (25% vs 34%), II (27% vs 24%), III (13% vs 13%), and IV (2% vs 2.5%). Groups had similar in-
hospital mortality (6.4% vs 11%; P¼ .11) and permanent stroke (4.4% vs 7.5%; P¼ .3). Permanent paraplegia
(3.6% vs 7.5%; P ¼ .01) and paraparesis (1.6% vs 6.3%; P ¼ .01) were significantly lower in the intrathecal
papaverine group.
Conclusions: Adding intrathecal papaverine to the neuroprotective protocol for descending thoracic aneurysm
and thoracoabdominal aortic aneurysm repairs may enhance spinal cord perfusion and provide additional spinal
cord protection. (J Thorac Cardiovasc Surg 2012;143:945-52)Supplemental material is available online.Surgery to replace diseased segments of the descending tho-
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Mspinal cord susceptible to ischemic injury and resultant para-
plegia or paraparesis.1 Concerted efforts to avoid these
dreaded complications have culminated in a cadre of various
neuroprotective adjuncts2-13 that to date have substantially
reduced but not completely eliminated the incidence of
spinal cord injury in modern series.4,6,12 Pharmacologic
neuroprotection with intrathecal papaverine (IP) is another
modality that may hold promising therapeutic
potential.10,14-17
Early in vivo studies revealed that IP completely pre-
vented paraplegia during aortic clamping in nonhuman
primates through a mechanism of enhanced vasodilation
and blood flow augmentation through the anterior spinal
artery.17 A more recent study of spinal cord injury in
nonhuman primates also corroborated the salutary ef-
fects of IP, documenting both marked increases in spinal
cord perfusion and preservation of myelin integrity.18
These striking experimental findings have been repro-
duced in subsequent clinical evaluations, including
a small randomized study of 33 patients in whom addi-
tion of IP to conventional modalities yielded signifi-
cantly enhanced freedom from disabling spinal cord
injuries.10,15rdiovascular Surgery c Volume 143, Number 4 945
FIGURE 1. Proportions of patients in whom intrathecal papaverine was
used during repair.
Abbreviations and Acronyms
AAA ¼ abdominal aortic aneurysm
CSF ¼ cerebrospinal fluid
DTA ¼ descending thoracic aortic aneurysm
HCA ¼ hypothermic circulatory arrest
IP ¼ intrathecal papaverine
TAAA ¼ thoracoabdominal aortic aneurysm
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MWe therefore initiated a prospective comparative effec-
tiveness study to assess whether adding IP to standard ad-
juncts would appreciably improve neurologic outcomes
after descending thoracic aortic aneurysm (DTA) and thor-
acoabdominal aortic aneurysm (TAAA) repairs.
MATERIALS AND METHODS
From January 2002 to January 2010, a total of 398 consecutive patients
underwent DTA and TAAA repairs, with 68 performed under conditions
of hypothermic circulatory arrest (HCA). These latter patients were ex-
cluded from our analysis. Among the remaining patients, 250 procedures
were performed with IP (IP group), whereas 80 procedures did not incor-
porate IP (non-IP group). The proportion of cases in which IP was used
increased over time (Figure 1). Primary data were prospectively collected
from the Cardiovascular Information Registry within the Heart and Vas-
cular Institute. This data entry repository has been approved for use in
research by the institutional review board, with patient consent waived.
Additionally, individual patient charts were reviewed for data confirma-
tion and acquisition of other values. Mean duration of follow-up was
3.9  2.6 years.
Pertinent patient demographic and clinical characteristics at the time of
surgery were investigated (Table 1). The groups shared a number of sim-
ilar preoperative characteristics, including mean age of 62 years, female
sex, body size, hypertension, degree of renal dysfunction, previous car-
diac surgery, previous stroke, and chronic obstructive pulmonary disease.
Almost all (>90%) of patients in both groups were in New York Heart
Association functional class I or II. Extent of aortic involvement, includ-
ing subtypes A through C for DTA and TAAA Crawford extents I through
IV, as well as presence of aortic dissection, were statistically indistin-
guishable between the 2 groups. The IP group included a greater propor-
tion of patients with peripheral arterial disease (62% vs 50%).
Conversely, non-IP group patients more frequently required emergency
operations (8% vs 0.8%, only 1 of whom had a neurologic deficit),
were less often completely free of symptoms (51% vs 71%), more com-
monly had previous infrarenal abdominal aortic aneurysm (AAA) repair
(18% vs 9%), and more often were seen with aortic rupture or contained
leak (15% vs 8%).
Preparation and Administration of Papaverine
Several prophylactic measures were taken to mitigate spinal cord is-
chemia. Before anesthetic induction, a cerebrospinal fluid (CSF) drainage
catheter was placed in 100% and 72% of the patients in the IP and non-IP
groups, respectively. In the IP group, 10 minutes before aortic clamping, 2
mL of CSF was withdrawn and 3 mL of warmed (37C) preservative-free
1% papaverine solution (in micropore-filtered solution with normal saline
solution) was infused intrathecally during 5 minutes to enable complete
dissolution in the CSF.10,15 After injection, the catheter was flushed
with 2 mL of CSF. For the duration of aortic clamping, the CSF was
allowed to drain freely by gravity. Postoperatively, CSF was drained
continuously to maintain intrathecal pressure below 10 cm H2O. Extent946 The Journal of Thoracic and Cardiovascular Surgof drainage was limited to 450 mL in a 24-hour period and 25 mL/h.
The pressure transducer was set at the level of the spinal entry point of
the CSF catheter.
Surgical Technique
The technique for DTA and TAAA repair has been previously de-
scribed.1,10 Briefly, all procedures were performed with some form of distal
aortic perfusion, by means of either cardiopulmonary or atriofemoral (left
heart) bypass. Before aortic clamping, active cooling was used to moderate
hypothermia, with targeted bladder temperature of 29C to 32C. Aortic
segments were sequentially clamped whenever possible to maintain
proximal and distal perfusion. Every effort was made to preserve critical
intercostal and lumbar vessels below the level of T6. Indeed, for repairs of
DTA extending below T8, all intercostal vessels (T8–T12) were
reimplanted; during TAAA repair, all visibly patent intercostal and lumbar
vessels were reimplanted. Monitoring of motor- or somatosensory-evoked
potentials was not routinely included in the intraoperative protocol.
Postoperative Monitoring and Neurologic
Assessment
All patients were comprehensively monitored during postoperative re-
covery in the intensive care unit, which encompassed continuous hemody-
namic (invasive) and serial neurologic evaluation. For the latter, lower limb
motor function was also prospectively assessed and scored twice daily ac-
cording to a previously described mean motor score.10 In this scoring sys-
tem, 0 corresponds to nomovement, 1 to flicker of movement, 2 to ability to
bend knee, 3 to inability to perform straight-leg raise against gravity, and 4
to normal movement and ambulation. Paraplegia was defined as a score of
0, and paraparesis was designated for scores between 1 and 3.
To maximize spinal cord perfusion, systemic mean arterial pressure
was maintained above 90 mm Hg. CSF drainage was continued for at least
48 hours. Before drain removal, a brief trial of capping the drain was per-
formed. In patients exhibiting signs of lower extremity weakness or paral-
ysis, the drain was maintained for longer duration of support. Reinsertion
of CSF drains was applied to patients who showed delayed lower limb pa-
ralysis or weakness. Concomitant with this practice were readmission to
the intensive care unit, arterial line monitoring, and pressor support as
necessary to achieve the desired level of spinal cord perfusion
augmentation.
End Points
Primary end points included 30-day in-hospital permanent paralysis or
paraplegia and death. Transient focal neurologic deficits were also recordedery c April 2012
TABLE 1. Preoperative patient characteristics
Characteristic
IP
(n ¼ 250)
No IP
(n ¼ 80)
P
value
Thoracic aorta disease (no.)
Aortic rupture or leak 19 (8%) 12 (15%) .05
Aortic dissection 114 (46%) 42 (53%) .3
Acute 5 (2%) 1 (1%) .7
Stanford type
A 48 (42%) 19 (45%) .7
B 66 (58%) 23 (55%)
DeBakey type
I 50 (44%) 19 (45%) .8
II 1 (0.9%) 0 (0%)
III 63 (55%) 23 (55%)
Descending thoracic aortic aneurysm* 86 (34%) 22 (28%) .6
A 43 (50%) 10 (45%)
B 17 (20%) 3 (14%)
C 26 (30%) 9 (41%)
Thoracoabdominal aortic aneurysm 165 (66%) 58 (72%)
Crawford type I 63 (25%) 27 (34%) .6
Crawford type II 66 (27%) 19 (24%)
Crawford type III 31 (13%) 10 (13%)
Crawford type IV 5 (2%) 2 (3%)
Demographic characteristics
Age (y, mean  SD) 62  12 62  13 .7
Sex (no. female) 93 (37%) 29 (36%) .9
Body mass index
(kg/m2, mean  SD)
27  5.0 28  5.6 .08
Acuity (no.)
Clinical presentation
No symptoms 178 (71%) 41 (51%) .0004
Occasional symptoms 57 (23%) 27 (34%)
Constant pain 15 (6%) 9 (11%)
Shock 0 (0%) 3 (4%)
Emergency operation 2 (0.8%) 6 (8%) .0007
New York Heart Association
functional class
I 152 (69%) 36 (56%) .03
II 59 (27%) 23 (36%)
III 9 (4%) 2 (3%)
IV 1 (0.5%) 3 (5%)
Cardiac comorbidities (no.)
Previous cardiac surgery 154 (62%) 54 (68%) .3
Hypertension 224 (90%) 71 (89%) .8
Stroke 54 (22%) 14 (18%) .4
Peripheral arterial disease 156 (62%) 40 (50%) .05
Noncardiac comorbidities
Chronic obstructive
pulmonary disease (no.)
88 (35%) 34 (43%) .2
Renal insufficiency (no.) 21 (8.4%) 8 (10% .7
Creatinine (mg/dL, mean  SD) 1.2  0.8 1.1  0.5 .6
Bilirubin (mg/dL, mean  SD) 0.5  0.3 0.6  0.6 .06
IP, Intrathecal papaverine. *Descending thoracic aortic aneurysm with extent classi-
fied as previously described by Svensson and associates.13
TABLE 2. Perioperative events after descending aortic thoracic
aneurysm and thoracoabdominal aortic aneurysm repairs
Event
IP
(n ¼ 250)
No IP
(n ¼ 80)
P
value
Permanent neurologic deficit (no.) 13 (5.2%) 11 (14%) .01
Paraplegia 9 (3.6%) 6 (7.5%) .01
Paraparesis 4 (1.6%) 5 (6.3%) .01
Cerebrospinal fluid drain
reinsertion (no.)
4 (1.6%) 6 (8.3%) .004
Stroke (no.) 11 (4.4%) 6 (7.5%) .3
In-hospital death (no.) 16 (6.4%) 9 (11%) .15
Dialysis (no.) 17 (6.8%) 13 (16%) .01
Reoperation for hemorrhage (no.) 10 (4.0%) 2 (2.5%) .5
Transfusion (units,15th/50th/85th
percentiles)
Packed red blood cells 1/4/11 0/4/13 .3
Fresh-frozen plasma 0/4/11 0/2/10 <.0001
Platelets 0/3/7 0/1/5.9 .001
Intensive care unit stay
(d, 15th/50th/85th percentiles)
2.8/4.7/9.5 2.3/6/22 .03
Postoperative stay
(d, 15th/50th/85th percentiles)
7/10/20 7/13/27 .02
IP, Intrathecal papaverine.
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Min the database (Table 2). Other recorded outcomes included stroke, renal
failure necessitating dialysis, prolonged ventilation (>24 hours), blood
product use, hemorrhage necessitating reoperation, and long-term survival.The Journal of Thoracic and CaThe Social Security Master Death File was used to identify vital status
and set back by 6 months to a common closing date of December 6, 2010.
Mean follow-up was 3.9  2.6 years (median, 3.9 years). Twenty-five per-
cent of survivors were followed up for 6.6 years or longer, and 10% were
followed up for longer than 8.3 years. Nonparametric survival estimates
were obtained by the Kaplan-Meier method and parametric estimates
were obtained by the multiphase hazard model.19
Data Analysis
Continuous data are expressed as mean  SD, with median, 15th, and
85th percentiles (comparable to SD) given for skewed values. Kruskal-
Wallis tests were used to analyze group differences for continuous data.
This nonparametric test accommodates highly skewed variables. Categoric
data are displayed as frequencies and percentages, and comparisons were
made with c2 tests (Fisher’s exact tests if appropriate).
Multivariable logistic regression analysis with variables listed in Table
E1 was performed to identify factors associated with neurologic deficit af-
ter DTA and TAAA repairs. Factors associated with IP were (1) more recent
date of operation (Figure 1 and 2) less likelihood of a previous infrarenal
aneurysm repair (see Table 1). The parsimonious model was augmented
with other available variables to form a propensity model (C ¼ 0.8, see
Table E1). Solving the resulting equation for each patient yielded a propen-
sity score (the probability of IP being used). Greedy matching based on the
propensity scores was then used to identify propensity-matched IP and non-
IP pairs. A total of 68 well-matched pairs were found (Figures E1 and E2).
Because twice-daily neurologic assessment was primarily 0 (no move-
ment) or 4 (normal movement), longitudinal repeated measures analysis of
the scores for the 30 patients with a neurologic deficit was of the dichoto-
mous variable neurologic deficit or not. For this, the SAS statistical soft-
ware package (SAS Institute, Inc, Cary, NC) procedure GENMOD was
used with a logit link.
RESULTS
Spinal Cord Injury
Unadjusted transient or permanent lower limb paralysis
or paraparesis was much less common among patients inrdiovascular Surgery c Volume 143, Number 4 947
FIGURE 2. Spinal cord injury after descending thoracic aortic (DTA) and
thoracoabdominal aneurysm repairs. A, Unadjusted and propensity-
matched outcomes of patients treated with (IP) or without (Non-IP) intra-
thecal papaverine. B, Outcomes stratified by extent of aortic disease for
papaverine (IP) group versus no papaverine (Non-IP) group.
FIGURE 3. Percentages of patients with a neurologic deficit who had any
movement through the first 5 postoperative days. Symbols are raw percent-
ages at each time point; solid line and 68% confidence bands are adjusted
for repeated measures.
TABLE 3. Incremental risk factors for permanent paralysis or
paraparesis
Factor Coefficient ± SE P value Ra
Associated with neurologic deficit
Previous infrarenal aneurysm
repair or stent
1.37  0.46 .003 68
Associated with no neurologic deficit
Active cooling 1.23  0.41 .003 49
Ra represents percentage of times variable appeared in 1000 bootstrap models. C sta-
tistic of this parsimonious model is 0.68.
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Mthe IP group (6% vs19%; P ¼ .0006). Permanent deficits
followed, with a frequency of 5.2% versus 14%
(P ¼ .01) for IP versus non-IP group, respectively. These
differences were maintained in the propensity-matched
groups (Figure 2, A). Prevalence of overall spinal cord in-
jury was 7.4% versus 18% for IP versus non-IP (P ¼ .07)
group patients, respectively, and prevalence of permanent
deficits was 7.4% versus 12% (P ¼ .4). A significantly
greater proportion of patients in the non-IP group required
postoperative CSF drain reinsertion for spinal cord injury
(8.3% versus 1.6%; P ¼ .004).
Eighteen (60%) of the 30 cases of spinal cord injury were
immediate, whereas 40% of these events presented beyond
24 hours postoperatively. In these groups, the percentage of
patients who had any movement scores less than 4 declined
through the first 5 postoperative days (P ¼ .03; Figure 3) at
the same rate (P ¼ .9 for difference in rate). Of the 9 CSF
drain reinsertions, all (100%) were performed in the setting
of delayed spinal cord injury.948 The Journal of Thoracic and Cardiovascular SurgStratification by aortic involvement yielded the following
for permanent spinal cord injury (IP versus non-IP):, DTA,
1.1% versus 0%; Crawford type I, 3.2% versus 26%;
Crawford type II, 9% versus 16%; Crawford type III,
13% versus 10%; and Crawford type IV, 0% versus 0%
(unadjusted; Figure 2, B).These deficits were further subca-
tegorized into permanent paraplegia (3.6% vs 7.5%) and
permanent paraparesis (1.6% vs 6.3%) for these respective
patient groups (Table 2). On multivariable logistic regres-
sion analysis, infrarenal AAA repair was independently
predictive of permanent paraplegia or paraparesis (hazard
ratio, 1.37; P ¼ .003; Table 3).
Other Outcomes
No adverse events attributable to IP administration oc-
curred. Patients in both groups received similar quantities
of packed red blood cells, with slightly greater amounts
of fresh–frozen plasma and platelets administered to those
in the IP group (see Table 2). Overall, however, the observed
occurrence of hemorrhage necessitating reoperation was
similarly low for both groups, 2.5% and 4% for non-IP
and IP groups, respectively. IP group patients had a signifi-
cantly reduced postoperative length of stay, including
shorter intensive care unit time. In-hospital mortality was
lower in the IP group (6.4% vs 11%), although thisery c April 2012
FIGURE 4. Early postoperative complications after descending and thor-
acoabdominal aneurysm repair. Patients receiving intrathecal papaverine
(IP) had significantly (P< .05) less renal failure necessitating dialysis
and decreased hospital stay (LOS) relative to patients with no intrathecal
papaverine (Non-IP).
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Mdifference was not statistically significant. When stratified
by extent of aortic disease, in-hospital mortalities for the
IP group versus the non-IP group were as follows: DTA,
3.6% versus 4.5%; Crawford type I, 4.8% versus 11%;
Crawford type II, 12% versus 16%; Crawford type III,
6.5% versus 10%; and Crawford type IV, 0% versus 50%.
Prevalences of permanent stroke (4.4% vs 7.5%) and renal
failure necessitating dialysis (6.8% vs 16%) were lower
among patients in the IP group, but only the latter difference
reached statistical significance (Figure 4). Any postoperative
paraplegia or paraparesis, whether transient or permanent,
portended a number of adverse outcomes. Specifically, these
patients had notably increased in-hospital mortality (20% vs
6.3%; P¼ .007), stroke (20% vs 3.7%; P¼ .001), and renal
failure (33% vs 6.7%;P<.0001). They also had significantly
prolonged stays, both overall (30 vs 13days;P<.0001) and in
the intensive care unit (19 vs 2.8 days; P<.0001). Examina-
tion of preoperative characteristics revealed that these pa-
tients had more extensive aortic involvement (Crawford
type II, 40% vs 24%; P¼ .02), higher prevalence of chronic
obstructive pulmonary disease (53% vs 35%; P ¼ .05), and
more frequent history of smoking (93% vs 75%; P ¼ .02).Long-Term Survival and Impact of Spinal Cord
Injury
On unadjusted analysis, there appeared to be a trend to-
ward improved long-term survival in the IP group; however,
this trend did not reach statistical significance (Figure 5, A).
Specifically, actuarial survivals at 1, 3, and 5 years were
87%, 81%, and 76% for the IP group versus 80%, 73%,
and 67% for the non-IP group. In the propensity-matched
groups, the trend toward improved survival for patients
with IP was less evident (Figure 5, B). In the matchedThe Journal of Thoracic and Cagroups, actuarial survivals at 1, 3, and 5 years were 84%,
79%, and 74% for the IP group versus 83%, 75%, and
67% for the non-IP group.
The IP and non-IP patient cohorts were combined to an-
alyze long-term survival stratified by sustained permanent
spinal cord injury after aneurysm repair (Figure 6). Patients
with these neurologic deficits had significantly diminished
long-term survival. Actuarial survivals at 1, 3, and 5 years
were 87%, 81%, and 75% for patients with no permanent
deficit versus 64%, 57%, and 51% for those with perma-
nent injury (P ¼ .002).
DISCUSSION
In this prospective series, addition of IP to modern neuro-
protective adjuncts considerably diminished occurrence of
spinal cord injury. The extent of this clinical benefit was
corroborated by propensity-matching analysis, although
the analysis was limited by insufficient power to demon-
strate statistical significance.
Laudable strides have been made in reducing periopera-
tive morbidity and mortality after DTA and TAAA repairs4;
however, these remain formidable operations for even the
most seasoned aortic surgeon. Probably the greatest source
of trepidation is the seemingly unavoidable yet finite risk of
disabling spinal cord injury implicit in these procedures, es-
pecially in patients with more extensive aortic disease
(Crawford types I and II). To this end, most centers have
adopted a multifaceted, multidisciplinary approach to max-
imize spinal cord protection. Clinically validated and
widely adopted facets of this strategy include segmental
aortic reconstruction with distal aortic perfusion through at-
riofemoral bypass to minimize duration of spinal cord is-
chemia,5,9,10 deliberate cooling to moderate hypothermia
(29C–32C) to diminish the metabolic demands of the
spinal cord,11 reimplantation of segmental intercostal and
lumbar arteries below T6,8,9 and lumbar CSF drainage to
optimize spinal cord perfusion.7,10,20
IPmay represent another key component of this neuropro-
tective regimen. The vasodilatory and neuroprotective prop-
erties ascribed to the opium derivative papaverine have been
previously elucidated in large animal in vivo studies,17,18 as
well as in small clinical series.10,15,16 With permanent
paraplegia and paraparesis occurrences of 3.6% and
1.6%, respectively, outcomes noted in the IP group in this
study compare favorably with those of other modern series
of both open4,6,12,20,21 and endovascular22 DTA and TAAA
repairs. In their series of 2286 TAAA (only) open surgical
repairs, Coselli and colleagues6 reported a 6.6% operative
mortality and 3.8% occurrence of paraplegia or paraparesis.
Primary features of the protective protocol used by these in-
vestigators included mild hypothermia, distal aortic perfu-
sion, intercostal and lumbar vessel reattachment, and CSF
drainage. The same authors, in a more recent iteration of
their surgical results in 509 patients, cited a permanentrdiovascular Surgery c Volume 143, Number 4 949
FIGURE 5. Long-term survival after descending thoracic aortic and thoracoabdominal aortic aneurysm repair. Each symbol represents a death positioned
on a vertical axis by the Kaplan-Meier estimator, vertical bars are confidence limits equivalent to SE, and numbers in parentheses are patients still alive
and traced at 6 months and at 1, 3, 5, and 7 years. Solid lines are parametric survival estimates enclosed within dashed 68% confidence bands equivalent to
SE. A, Survival after aneurysm repair procedure stratified by papaverine (IP) versus no papaverine (Non-IP) group (n¼ 330). B, Survival after aneurysm
repair stratified by papaverine (IP) versus no papaverine (Non-IP) group among matched patients (n ¼ 136; 68 matched pairs).
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tality.12 Prevalence of permanent paraplegia or paraparesis
was 9.5% overall. Notably, this series comprised a sizeable
proportion (20%) of urgent or emergency cases, including
5% of patients with frank rupture. As observed in this cur-
rent study, patients with the most extensive aortic involve-
ment (Crawford type II) had the greatest occurrence of
permanent spinal cord injury (11%).
In 2008, Etz and colleagues21 from Mount Sinai pub-
lished outcomes of 858 patients undergoing predominantly
DTA repair. Aside from the reported permanent paraplegia
occurrence of 2.7%, no additional data were provided re-
garding other adverse events, extent of aortic disease, or950 The Journal of Thoracic and Cardiovascular Surgother preoperative variables. The missing data unfortu-
nately preclude meaningful comparison with this study. Sa-
fi’s group20 summarized their 12-year experience with 238
mostly elective DTA repairs performed with distal aortic
perfusion and CSF drainage. Operative mortality was 8%,
with a 1.3% occurrence of spinal cord injury. Interestingly,
as noted in our own results section, previous infrarenal
AAA repair was predictive of spinal cord injury. This was
also observed by Svensson and colleagues13 in a series of
832 DTA repairs, as well as in a recent meta-analysis of
668 DTA and 825 TAAA repairs.23
In light of these findings, and the finding that a greater
proportion of the non-IP group had previous AAA repair,ery c April 2012
FIGURE 6. Survival after aneurysm repair stratified by permanent neurologic deficit. Format is as in Figure 5.
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Ma plausible criticism of our study is that the diminution in
spinal cord injury was not entirely attributable to IP but pos-
sibly was confounded by the disproportionately lower num-
ber of patients with AAA. Although this may be true, the
confirmed experimental and clinical efficacy of IP that pre-
dates this study cannot be readily dismissed. Furthermore,
the discrepancy in AAA history between these groups
may reflect an institutional bias favoring endovascular ap-
proaches in patients with previous distal AAA repairs.22
This practice shift coincided with the increasing use of IP
in open cases. Specifically, in a 2008 study from our institu-
tion comparing endovascular (n ¼ 352) and surgical
(n ¼ 372) approaches to DTA and TAAA, a significantly
greater proportion of patients undergoing endovascular re-
pair (28% vs 16%; P<.001) had previous distal aortic sur-
gery.22 Prevalence of spinal cord injury was 4.3% in the
endovascular group, compared with 7.5% in the surgical
group. Use of IP in our practice has further narrowed this
margin of disparity from 3.2% (7.5% minus 4.3%) to
0.9% (5.2% minus 4.3%), a 3-fold improvement in spinal
cord injury outcomes with open surgical repair. On the basis
of these results and the routine use of CSF drains in endo-
vascular procedures, the added benefit of including IP
also appears justifiable in these cases.
Procedures performed with HCA were excluded from
analysis in this study. Some groups espouse HCA as the
optimal mode of spinal cord protection that should be ap-
plied in most DTA and TAAA repairs.24,25 Clearly, in
cases where the proximal aorta cannot be clamped or
concomitant arch pathology mandates surgical correction,
HCA is a requisite tool. Otherwise, however, the routine
use of HCA in DTA and TAAA repairs is debatable and
fraught with conflicting reports in the literature with
regard to safety and efficacy.11,24-27 Low levels (<4%) ofThe Journal of Thoracic and Caspinal cord injury have been reported with HCA, but
often at the expense of increased operative mortality
(11%–29%), stroke (9%–11%), and renal (11%–15%)
and respiratory (22%) failure, even at highly regarded
aortic centers of excellence.26,27
As described in our own methods section, there are some
important points to adhere to when using IP. First, a preser-
vative-free solution should be used, because preservatives
in local anesthetics injected intrathecally may irritate
tissues. The solution is therefore mixed on a monthly basis,
although preservative-free papaverine is also available. Sec-
ond, the solution should be at body temperature, because
cold solutions injected intrathecally can cause a sympathetic
response with systemic blood pressure drop. We have not
observed any complications related to the solution, but
these precautions are important.
Limitations
The nonrandomized design of this prospective study hin-
ders extrapolation of the results towidespread clinical adop-
tion. In part, lack of equipoise for a randomized trial
stemmed from both animal and small clinical studies that
all pointed in the same direction. Use of propensity scores
has become standard in comparative effectiveness studies;
however, this method cannot account for unmeasured selec-
tion factors. Likewise, given some distinguishable charac-
teristics of the control non-IP group, propensity matching
would have further bolstered the validity of the outcomes
if a larger cohort of patients had been studied.
CONCLUSIONS
Inclusion of IP in a conventional strategy of spinal cord
protection reduced the frequency of spinal cord injury after
open surgical DTA and TAAA repairs. Further studies, withrdiovascular Surgery c Volume 143, Number 4 951
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Mlarger cohorts of patients evaluated in a prospective, ran-
domized fashion, will be valuable to solidify the claims to
efficacy of this neuroprotective modality. The therapeutic
potential of this pharmacologic adjunct may also be realized
in endovascular therapies for complex thoracic aorta dis-
ease. Future prospective, randomized studies in both the
open surgical and endovascular arenas may confirm the
neuroprotective benefits of IP.
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FIGURE E1. Mirrored histogram of distribution of propensity scores for
papaverine versus no papaverine groups. Shaded area represents matched
patient pairs.
FIGURE E2. Covariable balance description before and after matching
between papaverine and no-papaverine groups. NYHA, New York Heart
Association functional class; Prev, previous; BMI, body mass index; MI,
myocardial infarction; PAD, peripheral arterial disease.
TABLE E1. Variables considered in analysis
Category Variables
Demographic Age (y),* sex*, ethnicity (white),* ethnicity
(black), height (cm), weight (kg), body surface
area (m2), body mass index (kg/m2)*
Experience Interval to operation since Jan 1, 2002 (y)*
Symptoms New York Heart Association functional class
(I–IV)*
Ventricular function Previous myocardial infarction*
Cardiac comorbidity Ventricular arrhythmia,* previous cardiac
surgery, congestive heart failure
Noncardiac
comorbidity
Bilirubin (mg/dL),* creatinine (mg/dL),* blood
urea nitrogen (mg/dL),* hematocrit (%),*
peripheral arterial disease,* history of carotid
disease, history of hypertension, history of
treated diabetes,* history of chronic
obstructive pulmonary disease, smoking
(history or current), history of renal disease,
history of stroke
Procedure Concomitant aortic root or arch replacement or
ascending aortic procedure, rupture or leak,*
dissection,* extent of aneurysm into
descending aorta,* previous infrarenal
aneurysm repair or stent*
*Variables included in propensity model.
TABLE E2. Parsimonious model of intrathecal papaverine versus no
intrathecal papaverine
Factor Coefficient ± SE P value Ra
Associated with intrathecal papaverine
More recent date of surgery 0.37  0.07 <.0001 77
Associated with no intrathecal papaverine
Previous infrarenal aneurysm
repair or stent
0.88  0.4 .03 58
Ra represents percentage of times variable appeared in 1000 bootstrap models. C sta-
tistic of this parsimonious model is 0.73.
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